login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Account
Disclaimer
Affiliate
Contact
Privacy
VIRPAX PHARMACEUTICALS INC (VRPX) Stock News
USA
- NASDAQ:VRPX -
US9282512063
-
Common Stock
0.6695
USD
-0.55 (-45.12%)
Last: 4/3/2025, 8:04:03 PM
0.4498
USD
-0.22 (-32.82%)
After Hours:
4/3/2025, 8:04:03 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
VRPX Latest News, Press Relases and Analysis
All
Press Releases
6 months ago - By: Benzinga
- Mentions:
SGMO
IBO
ALDX
BBLG
...
12 Health Care Stocks Moving In Thursday's After-Market Session
6 months ago - By: Benzinga
- Mentions:
PTIX
IBO
ALDX
APVO
...
11 Health Care Stocks Moving In Thursday's Intraday Session
6 months ago - By: Virpax Pharmaceuticals, Inc.
Virpax Pharmaceuticals Announces Reverse Stock Split
6 months ago - By: Virpax Pharmaceuticals, Inc.
Virpax Receives Positive Probudur™ Results for Dose Range Study Moves Towards Next Steps in IND
7 months ago - By: Virpax Pharmaceuticals, Inc.
Virpax Looking to Use MET to Develop Intranasal COVID Vaccine
7 months ago - By: Virpax Pharmaceuticals, Inc.
Virpax’s NES100 to be Presented at The Society of Toxicology by NCATS
7 months ago - By: Virpax Pharmaceuticals, Inc.
Virpax Reports Positive Results in Human Study for its Molecular Envelope Technology
Please enable JavaScript to continue using this application.